Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Avir    crawled time : 12:01    save search
Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Virology Trial of AT-527 in Outpatient Setting
Published: 2021-02-04 (Crawled : 12:01) - globenewswire.com
AVIR | $3.71 19K twitter stocktwits trandingview |
Health Technology
 | | O: 0.52% H: 2.5% C: -7.63%
phase 2 trial at-527 set
Gainers vs Losers
48% 52%

Top 10 Gainers
AGBA | $1.44 260.0% 40M twitter stocktwits trandingview |
Finance
BPTH | $6.25 92.9% 20M twitter stocktwits trandingview |
Health Technology
EGOX | $0.0447 39.25% 24M twitter stocktwits trandingview |

BNTC | $5.91 23.13% 1.3M twitter stocktwits trandingview |
Health Technology
XPON | $2.33 20.73% 410K twitter stocktwits trandingview |

BRSH | $0.0515 15.99% 12M twitter stocktwits trandingview |
n/a
VTNR S | $1.12 14.38% 470K twitter stocktwits trandingview |
Industrial Services
DXYZ 4 | $33.49 13.41% 210K twitter stocktwits trandingview |
n/a
BMI 4 | $169.84 11.01% 68K twitter stocktwits trandingview |
Producer Manufacturing
CTM | $0.244 10.86% 40K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.